BP Capital Markets PLC Publication of Suppl.Prospcts (1734F)

TIDM74WM

RNS Number : 1734F

BP Capital Markets PLC

05 March 2020

Publication of Supplementary Prospectus

The following supplementary prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Supplementary prospectus dated 5 March 2020 (the "Supplementary Prospectus") relating to the prospectus dated 2 July 2019, as supplemented by the supplementary prospectus dated 7 November 2019 (the "Prospectus"), for the U.S.$30,000,000,000 Debt Issuance Programme issued by BP Capital Markets p.l.c. unconditionally and irrevocably guaranteed by BP p.l.c.

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/1734F_1-2020-3-5.pdf

A copy of the Supplementary Prospectus and the documents incorporated by reference therein will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM .

For further information, please contact:

BP Capital Markets p.l.c.

20 Canada Square

Canary Wharf

London E14 5NJ

United Kingdom

   Tel:             [phone] 
   Fax:            [phone] 
   Attention:   Gary Admans 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus and Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the Prospectus and Supplementary Prospectus is not addressed. Prior to relying on the information contained in the Prospectus and Supplementary Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

The Prospectus and Supplementary Prospectus does not constitute an offer of securities for sale in the United States. The securities described in the Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, or under any relevant securities laws of any state of the United States of America and may not be offered, sold or delivered in the United States of America or to, or for the account of or benefit of, U.S. Persons, subject to certain limited exemptions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

PSPDZGGFZKGGGZM

(END) Dow Jones Newswires

March 05, 2020 07:43 ET (12:43 GMT)